TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17082283

Group type: EXPERIMENTAL
Intervention: A100 (4% articaine HCl with 1:100,000 epinephrine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: A200 (4% articaine HCl with 1:200,000 epinephrine)
Number of subjects: 0
Study: 14677105

Group type: EXPERIMENTAL
Intervention: Comprehensive Cohort Design (CCD)
Number of subjects: 0
Study: 10776974

Group type: EXPERIMENTAL
Intervention: Tiorfan (racecadotril) 300 mg/day from D0 to D15
Number of subjects: 136

Group type: COMPARATOR
Intervention: No prophylactic treatment
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Tiorfan (racecadotril) 300 mg/day
Number of subjects: 136
Study: 8942437

Group type: EXPERIMENTAL
Intervention: Cigarette smoking, diabetes, high cholesterol, and hypertension in Mexican Americans
Number of subjects: 2629

Group type: COMPARATOR
Intervention: Cigarette smoking, diabetes, high cholesterol, and hypertension in non-Hispanic whites
Number of subjects: 2629
Study: 1534528

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LCCE)
Number of subjects: 77

Group type: COMPARATOR
Intervention: mini-lap cholecystectomy (mini-lap CCE)
Number of subjects: 77
Study: 3939598

Group type: EXPERIMENTAL
Intervention: Geriatric Special Care Units (GSCUs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional adult medical/surgical unit
Number of subjects: 0
Study: 31356535

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) 0.5-µg/kg overload dose for 10 minutes and a 0.5-μg/kg/h maintenance dose
Number of subjects: 28

Group type: COMPARATOR
Intervention: Non-DEX (saline)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 28
Study: 29793345

Group type: EXPERIMENTAL
Intervention: Dignity Therapy (DT)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Standard Palliative Care (Control)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Client-Centered Care (Control)
Number of subjects: 326
Study: 27552270

Group type: EXPERIMENTAL
Intervention: COMPASS Total Worker Health intervention
Number of subjects: 149
Study: 24951180

Group type: EXPERIMENTAL
Intervention: Tailored multifactorial interventions
Number of subjects: 300

Group type: COMPARATOR
Intervention: Lifestyle advice with continued conventional care (Control)
Number of subjects: 300
Study: 22281837

Group type: EXPERIMENTAL
Intervention: Virtual coach intervention (automated, animated computer agent providing personalized feedback and goal setting)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Pedometer and website alone (control group)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Virtual coach intervention
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Virtual coach intervention and control group
Number of subjects: 70
Study: 20826253

Group type: EXPERIMENTAL
Intervention: Smoking cessation pharmacotherapies
Number of subjects: 1504

Group type: EXPERIMENTAL
Intervention: Smoking intensity (cigarettes per day, pack-years, carbon monoxide, Fagerström Test of Nicotine Dependence)
Number of subjects: 1504

Group type: EXPERIMENTAL
Intervention: Smoking intensity (pack-years, cigarettes per day, carbon monoxide, Fagerström Test of Nicotine Dependence)
Number of subjects: 1504

Group type: EXPERIMENTAL
Intervention: Waist circumference and triglycerides
Number of subjects: 1504
Study: 18420471

Group type: EXPERIMENTAL
Intervention: Botulinum Toxin A (120 U into the antrum and 80 U into the fundus)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 30
Study: 15964595

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 18
Study: 12943892

Group type: EXPERIMENTAL
Intervention: candesartan
Number of subjects: 73

Group type: COMPARATOR
Intervention: lisinopril
Number of subjects: 73
Study: 10220228

Group type: EXPERIMENTAL
Intervention: Real motor task (little and index finger abduction)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Mental non‐motor activity (arithmetical calculation)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Mental simulation of selective index finger or little finger abduction
Number of subjects: 7

Group type: COMPARATOR
Intervention: Full muscular and mental relaxation
Number of subjects: 7
Study: 7759438

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (n = 6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (n = 6)
Number of subjects: 12
Study: 1983344

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg q.d.s. for 1 week
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg nocte for 1 week
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sufotidine 300 mg b.d. for 1 week
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sufotidine 600 mg b.d. for 14 days
Number of subjects: 0
Study: 384248

Group type: EXPERIMENTAL
Intervention: Warfarin sodium
Number of subjects: 68

Group type: COMPARATOR
Intervention: Subcutaneous heparin
Number of subjects: 68
Study: 31820601

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Jingtong granule
Number of subjects: 114

Group type: COMPARATOR
Intervention: Jingtong granule (4 g, 3 times a day)
Number of subjects: 114
Study: 27798369

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 215

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 215
Study: 26156174

Group type: EXPERIMENTAL
Intervention: Involvement of service users at strategic, site, and local levels in the SAFER 2 trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Additional strategic level forums (Task and Finish Groups and Writing Days)
Number of subjects: 0
Study: 23225093

Group type: EXPERIMENTAL
Intervention: Topical and intracameral anesthesia without sedation during first eye surgery
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Topical and intracameral anesthesia without sedation during second eye surgery
Number of subjects: 60
Study: 21916971

Group type: EXPERIMENTAL
Intervention: Single or double dose of MF59-adjuvanted influenza A(H1N1) vaccine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Seasonal influenza vaccine (virosome-adjuvanted trivalent influenza vaccine)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pandemic vaccine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Local adverse events at the injection site of pandemic vaccine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Local adverse events at the injection site of seasonal vaccine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Solicited systemic adverse events
Number of subjects: 80
Study: 18699786

Group type: EXPERIMENTAL
Intervention: 17% EDTA and 5% NaOCl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 17% EDTA and 2.5% NaOCl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5% NaOCl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl
Number of subjects: 60

Group type: COMPARATOR
Intervention: saline solution
Number of subjects: 60
Study: 16504463

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (CARDIO) 3 days/week, 45 min/day for 10 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Flexibility/strength exercise (FLEX) 3 days/week, 45 min/day for 10 months
Number of subjects: 0
Study: 12755970

Group type: EXPERIMENTAL
Intervention: Sunscreen cream use
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Alternative protective measures (limited exposure during peak sun hours, use of shade, protective clothing and hats)
Number of subjects: 360
Study: 11224990

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New chemotherapeutic agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biological agents
Number of subjects: 0
Study: 9507382

Group type: EXPERIMENTAL
Intervention: Large-volume leukapheresis (LVL)
Number of subjects: 32
Study: 7984977

Group type: EXPERIMENTAL
Intervention: Beta-lactam antibiotics for 10 days
Number of subjects: 54
Study: 2499172

Group type: EXPERIMENTAL
Intervention: Occupational Work Evaluation
Number of subjects: 201

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 201
Study: 18962621

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d
Number of subjects: 4731

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4731
Study: 106746

Group type: EXPERIMENTAL
Intervention: Oral cromoglycate
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 30700318

Group type: EXPERIMENTAL
Intervention: ProYouth plus a structured dissonance‐based module
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: ProYouth plus a CBT‐based chat group intervention
Number of subjects: 309

Group type: COMPARATOR
Intervention: ProYouth (active control condition)
Number of subjects: 309
Study: 26700792

Group type: EXPERIMENTAL
Intervention: DPREMB‐R morning score
Number of subjects: 0
Study: 27072812

Group type: EXPERIMENTAL
Intervention: Repaired tendons at 3 months
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Repaired tendons at 6 months
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Repaired tendons at 12 months
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Tendon core at 3 months
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Tendon core at 6 months
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: ATRS at 6 months
Number of subjects: 23
Study: 25010793

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Canagliflozin 200 mg
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 22731733

Group type: EXPERIMENTAL
Intervention: Immediate brief cessation intervention
Number of subjects: 214

Group type: COMPARATOR
Intervention: Delayed brief cessation intervention
Number of subjects: 214
Study: 18834673

Group type: EXPERIMENTAL
Intervention: Dose-escalated radiation and concurrent temozolomide
Number of subjects: 26

Group type: COMPARATOR
Intervention: Inadequate PET-GTV coverage
Number of subjects: 26
Study: 17846260

Group type: EXPERIMENTAL
Intervention: Tadalafil 10 mg
Number of subjects: 186

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186
Study: 15236782

Group type: EXPERIMENTAL
Intervention: Probenecid 250 mg twice daily for seven days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Probenecid
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 12049858

Group type: EXPERIMENTAL
Intervention: Fondaparinux 2.5 mg, starting postoperatively
Number of subjects: 2309

Group type: COMPARATOR
Intervention: Enoxaparin 40 mg, starting preoperatively
Number of subjects: 2309

Group type: EXPERIMENTAL
Intervention: Fondaparinux
Number of subjects: 2309

Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 2309
Study: 9804592

Group type: EXPERIMENTAL
Intervention: Sufentanil (0.2 microgram/kg iv)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 62

Group type: COMPARATOR
Intervention: Naloxone (0.15 mg/kg iv)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Air exposure
Number of subjects: 62
Study: 8983937

Group type: EXPERIMENTAL
Intervention: Capsule formulation of thiocolchicoside (8 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Tablet formulation of thiocolchicoside (8 mg)
Number of subjects: 8
Study: 2654967

Group type: EXPERIMENTAL
Intervention: amitriptyline
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: pirlindol
Number of subjects: 21
Study: 794665

Group type: EXPERIMENTAL
Intervention: Hydergin (3 mg daily)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 29756693

Group type: EXPERIMENTAL
Intervention: Multi-parametric pGDT
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 140
Study: 28489046

Group type: EXPERIMENTAL
Intervention: MicroMini Motionlogger® Actigraph
Number of subjects: 0
Study: 25816031

Group type: EXPERIMENTAL
Intervention: Trunk restraint group (TRG) - reaching training with trunk restraint
Number of subjects: 20

Group type: COMPARATOR
Intervention: Trunk free group (TFG) - unrestraint reaching
Number of subjects: 20
Study: 23640314

Group type: EXPERIMENTAL
Intervention: Lumbopelvic belt plus information
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Home based pelvic stabilizing exercises plus information
Number of subjects: 105

Group type: COMPARATOR
Intervention: Information alone (Control group)
Number of subjects: 105
Study: 21939822

Group type: EXPERIMENTAL
Intervention: CCTA
Number of subjects: 699
Study: 19370821

Group type: EXPERIMENTAL
Intervention: Aspheric IOL (Tecnis Z9000)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Spherical IOL (AcrySof SA60AT)
Number of subjects: 20
Study: 17110814

Group type: EXPERIMENTAL
Intervention: STS 6 mg/24 h
Number of subjects: 322

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 322
Study: 15322328

Group type: EXPERIMENTAL
Intervention: Alprostadil (PGE(1), Prostavasin, intravenous, infusion rate: 0.38 microg/h/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 11285377

Group type: EXPERIMENTAL
Intervention: Prednisolone 7.5 mg daily over 2 years
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 28
Study: 9314456

Group type: EXPERIMENTAL
Intervention: Aplisol
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Tubersol
Number of subjects: 51

Group type: COMPARATOR
Intervention: Aplisol and Tubersol
Number of subjects: 51
Study: 8212108

Group type: EXPERIMENTAL
Intervention: Insecticide-treated bed nets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemoprophylaxis
Number of subjects: 0
Study: 3537815

Group type: EXPERIMENTAL
Intervention: Classical radical mastectomy by Halsted
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: Mastectomy by Patey
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: Conservative operation of radical resection type
Number of subjects: 816
Study: 31482684

Group type: EXPERIMENTAL
Intervention: Curcumin nanomicelle (40 mg, 3 times a day for 12 weeks)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (3 times a day for 12 weeks)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Curcumin nanomicelle
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 28187466

Group type: EXPERIMENTAL
Intervention: 100 mg Mangifera indica fruit powder
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 300 mg Mangifera indica fruit powder
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 26133902

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (CHM), standardized extract of 7 selected ingredients, 5 capsules twice daily for 8 weeks.
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (CHM)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 125
Study: 23419916

Group type: EXPERIMENTAL
Intervention: Kinesio Taping Method with convolutions in neutral position (10-15% tension, treated muscles in stretching position)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Kinesio Taping without convolutions in neutral (0% tension, treated muscles in resting position)
Number of subjects: 148
Study: 21200334

Group type: EXPERIMENTAL
Intervention: Bare Metal Stent (BMS)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Paclitaxel-Eluting Stent
Number of subjects: 97

Group type: COMPARATOR
Intervention: Drug-Eluting Stent (DES)
Number of subjects: 97
Study: 18506009

Group type: EXPERIMENTAL
Intervention: Radial artery graft
Number of subjects: 142

Group type: COMPARATOR
Intervention: Saphenous vein graft
Number of subjects: 142
Study: 16680486

Group type: EXPERIMENTAL
Intervention: Traffic police (exposed to urban pollutants)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Controls (not exposed to urban pollutants)
Number of subjects: 100
Study: 12540632

Group type: EXPERIMENTAL
Intervention: C-Peptide (600 nmol/24 h, four doses s.c.)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: C-Peptide
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 11712303

Group type: COMPARATOR
Intervention: Lidocaine administered intravenously (single dose over 2 minutes)
Number of subjects: 31
Study: 8886554

Group type: EXPERIMENTAL
Intervention: tolrestat
Number of subjects: 738
Study: 1813733

Group type: EXPERIMENTAL
Intervention: Cefuroxime (1.5 g single dose)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cefoxitin (2 g triple dose)
Number of subjects: 200
Study: 6181113

Group type: EXPERIMENTAL
Intervention: Ragweed allergoid administered in a clustered regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebos in a clustered regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unaltered ragweed extract (allergen) in a weekly regimen
Number of subjects: 0
Study: 31858126

Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy (intramuscular injections every 2 weeks for 22 weeks)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo (intramuscular injections every 2 weeks for 22 weeks)
Number of subjects: 64
Study: 30506519

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 226

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 226
Study: 28929513

Group type: EXPERIMENTAL
Intervention: HbA1c levels
Number of subjects: 87
Study: 26531092

Group type: EXPERIMENTAL
Intervention: Flowable composite with adhesive system (Tetric EvoFlow)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Highly filled pit-and-fissure sealant (Fissurit FX)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Highly filled nano-hybrid pit-and-fissure sealant (Grandio Seal)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Self-adhesive flowable composite (Vertise Flow)
Number of subjects: 4
Study: 24148053

Group type: EXPERIMENTAL
Intervention: Home to Stay
Number of subjects: 330

Group type: COMPARATOR
Intervention: Standard shelter services
Number of subjects: 330
Study: 21295880

Group type: EXPERIMENTAL
Intervention: Accelerated fractionation (AF) - 1.1Gy+2.0Gy/day, 5days/week for 4.5weeks, total dose 68Gy
Number of subjects: 750

Group type: COMPARATOR
Intervention: Conventional fractionation (CF) - 2Gy/day, 5days/week for 7 weeks, total dose 68Gy
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Accelerated fractionation (AF)
Number of subjects: 750
Study: 19275947

Group type: EXPERIMENTAL
Intervention: Self-referred recruitment strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Outreach recruitment strategy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comprehensive assessment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abbreviated assessment
Number of subjects: 0
Study: 16917558

Group type: EXPERIMENTAL
Intervention: Submucosal cauterization with outfracture
Number of subjects: 20

Group type: COMPARATOR
Intervention: Submucosal cauterization without outfracture
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 14961966

Group type: EXPERIMENTAL
Intervention: Ozonated autohemotherapy (O3‐AHT) with ozone concentration of 50 micro g/ml
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (autohemotherapy with oxygen)
Number of subjects: 12
Study: 11098980

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (NO)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (no inhaled NO)
Number of subjects: 42
Study: 8342093

Group type: EXPERIMENTAL
Intervention: Helium insufflation
Number of subjects: 20

Group type: COMPARATOR
Intervention: CO2 insufflation
Number of subjects: 20
Study: 3523663

Group type: EXPERIMENTAL
Intervention: 500 micrograms terbutaline in one inhalation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 125 micrograms terbutaline in four inhalations taken in rapid succession
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 125 micrograms terbutaline in four inhalations taken with an intervening time interval of 30 min
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 500 micrograms terbutaline
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 2 or 3 X 125 micrograms terbutaline with an intervening time interval of 30 min
Number of subjects: 12
Study: 31978126

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) - 30 breaths twice-daily at 50% of maximal inspiratory pressure (MIP) for 8 weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: Otago Exercise Program (OEP) - Resistance and mobility exercises for 60 minutes, twice-weekly for 8 weeks
Number of subjects: 37
Study: 28857451

Group type: EXPERIMENTAL
Intervention: Ertugliflozin 5 mg/d
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Ertugliflozin 15 mg/d
Number of subjects: 621

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 621
Study: 27731956

Group type: EXPERIMENTAL
Intervention: TAP block after induction of general anesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 60
Study: 25341356

Group type: EXPERIMENTAL
Intervention: Xuebijing Injection 50 mL Bid
Number of subjects: 56

Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 56
Study: 21924397

Group type: EXPERIMENTAL
Intervention: Closure of peritoneum
Number of subjects: 533

Group type: COMPARATOR
Intervention: Nonclosure of peritoneum
Number of subjects: 533
Study: 19959538

Group type: EXPERIMENTAL
Intervention: 20 microg/kg rFVIIa
Number of subjects: 841

Group type: EXPERIMENTAL
Intervention: 80 microg/kg rFVIIa
Number of subjects: 841

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 841

Group type: EXPERIMENTAL
Intervention: rFVIIa (combined)
Number of subjects: 841
Study: 19317950

Group type: EXPERIMENTAL
Intervention: Biologic agents
Number of subjects: 0
Study: 16002493

Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation program (4 physical therapy sessions)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Standard physical therapy-supervised rehabilitation program (17 physical therapy sessions)
Number of subjects: 145
Study: 12781412

Group type: EXPERIMENTAL
Intervention: Injection of Tc-99m labelled albumin particles before sterilization
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Injection of Tc-99m labelled albumin particles after sterilization
Number of subjects: 10
Study: 10573447

Group type: EXPERIMENTAL
Intervention: Agitated Behavior in Dementia scale (ABID)
Number of subjects: 148
Study: 8756029

Group type: EXPERIMENTAL
Intervention: Saliva collected with the Omni‐SAL device tested with GACELISA
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Conventional serum Western blot kit
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Saliva collection method
Number of subjects: 325